University of Ioannina
Η χρήση της ανθρώπινης ανασυνδυασμένης ερυθροποιητίνης στην αντιμετώπιση της αναιμίας της κύησης και της λοχείας
Abstract
dc:descriptionThe physiology of maternal and fetal erythropoiesis in pregnancy shows that haematopoiesis, and the stimulation of hemopoiesis, take place separately in two independent circulations. Erythropoietin appears the main stimulator of erythropoiesis in both mother and fetus. The human placenta forms a manifest barrier, to endogenous and recombinant erythropoietin in the treatment of maternal pregnancy anaemia. The prevalence of maternal anaemia in pregnancy and post-partum is high, up to 90% of cases are due to iron deficiency, compounded post-partum by blood loss during and after delivery. The use of recombinant human erythropoietin improved psychological wellbeing of these patients. We recommend administration of s.c. rHuEPO 200 iu/kg, with 200 mg Fe and 5 mg Fillicine for treatment of anaemia in pregnancy and post-partum, under medical care.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lialios, Georgios
- Λιάλιος, Γεώργιος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21367